Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-062613

Chief Medical Officer sold 6,250 shares at an average $50.41 ($315,088)

  • Chief Medical Officer acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BALDO LANCE · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-07 Exercise or conversion : show line 1 in the form +6,250 $7.80 $48,750 6,250 D
2020-12-07 Sale : show line 2 in the form −780 $48.79 $38,056 5,470 D
2020-12-07 Sale : show line 3 in the form −3,000 $50.14 $150,420 2,470 D
2020-12-07 Sale : show line 4 in the form −2,470 $51.26 $126,612 0 D
Open-market sales · 6,250 sh · avg $50.41 · $315,088

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-07 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −6,250 381,250 D
Loading xslF345X03/doc4.xml…